Abstract
BackgroundThe study of genetic variants of enzymes in the metabolic pathways of folic acid has provided conflicting results regarding toxicity or clinical response to methotrexate (MTX). There are several reasons...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
